NHS Dudley Health Economy Medicines Formulary
Home > 9 Nutrition and blood > 9.1 Anaemias and some other blood disorders > 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias > Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA142) - NICE TAG TA323

Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA142) - NICE TAG TA323

1.1 Erythropoiesis‑stimulating agents (epoetin alfa, beta, theta and zeta, and darbepoetin alfa) are recommended, within their marketing authorisations, as options for treating anaemia in people with cancer who are having chemotherapy.

1.2 If different erythropoiesis‑stimulating agents are equally suitable, the product with the lowest acquisition cost for the course of treatment should be used.

https://www.nice.org.uk/guidance/ta323

Site by Devopa
© Copyright 2021 NHS. All rights reserved.